XTL Biopharmaceuticals Ltd.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-1.9M | $-1.9M | $2.0K | $140.0K |
| FY2016 | $-1.7M | $-1.7M | $2.0K | $175.0K |
| FY2017 | $-1.1M | $-1.1M | — | $37.0K |
| FY2018 | $-816.0K | $-816.0K | — | $22.0K |
| FY2019 | $-908.0K | $-910.0K | $2.0K | $5.0K |
| FY2020 | $-850.0K | $-851.0K | $1.0K | $51.0K |
| FY2021 | $-1.0M | $-1.0M | — | $37.0K |
| FY2022 | $-901.0K | $-901.0K | — | $14.0K |
| FY2023 | $-707.0K | $-707.0K | — | — |
| FY2024 | $-1.6M | $-1.7M | $54.0K | — |